Table 3 Energy-, carbohydrate and lipid metabolic biomarkers of male subjects of the BiliHealth study.
MALES | Variable | Mean° (±sd)/median^ (IQR) | p-value */T | |
---|---|---|---|---|
GS | C | |||
Biomarkers of energy metabolism | pAMPK α1/α2 [rfU]^ | 201 (91) n = 39 | 107 (39) n = 37 | 0.000* |
pPpar α [rfU]° | 385 (±84) n = 38 | 296 (±90) n = 39 | 0.000* | |
pPpar γ [rfU]^ | 1384 (365) n = 39 | 1049 (438) n = 39 | 0.003* | |
PgC 1α [rfU]^ | 205 (53) n = 39 | 158 (56) n = 39 | 0.000* | |
AMPK α1 expr. [RQ]^ | 0.76 (0.24) n = 40 | 0.78 (0.25) n = 40 | 0.729 | |
Sirt-1 [ng/mL]^ | 3.26 (1.66) n = 31 | 3.24 (1.77) n = 34 | 0.887 | |
FGF-21 [μg/mL]^ | 0.33 (0.38) n = 34 | 0.13 (0.41) n = 34 | 0.147 | |
TSH [μU/mL]° | 1.8 (±0.8) n = 38 | 1.9 (±0.9) n = 39 | 0.372 | |
T3 [pg/mL]° | 3.37 (±0.32) n = 39 | 3.31 (±0.39) n = 39 | 0.476 | |
T4 [ng/dL]^ | 1.30 (0.20) n = 39 | 1.27 (0.20) n = 39 | 0.163 | |
BMI [kg/m2]^ | 22.5 (3.6) n = 40 | 24.9 (5.9) n = 40 | 0.023* | |
LBM [%]^ | 79.4 (7.0) n = 40 | 80.9 (9.0) n = 38 | 0.838 | |
Biomarkers of carbohydrate metabolism | Glucose [mg/dL]° | 81 (7) n = 39 | 86 (11) n = 40 | 0.016* |
HbA1c [%]^ | 5.0 (0.4) n = 40 | 5.1 (0.5) n = 40 | 0.150 | |
C-Peptide [ng/mL]^ | 1.2 (0.7) n = 39 | 1.3 (1.1) n = 39 | 0.009* | |
Insulin [μU/mL]^ | 3.9 (2.4) n = 36 | 6.1 (5.8) n = 39 | 0.001* | |
Biomarkers of lipid metabolism | TChol [mg/dL]^ | 165 (49) n = 39 | 180 (71) n = 40 | 0.344 |
HDL Chol [mg/dL]° | 58 (±15) n = 39 | 57 (±14) n = 40 | 0.761 | |
LDL Chol [mg/dL]^ | 94 (36) n = 39 | 109 (70) n = 40 | 0.410 | |
LDL/HDL ratio^ | 1.6 (1.0) n = 39 | 1.8 (1.3) n = 40 | 0.315 | |
TG [mg/dL]^ | 73 (31) n = 38 | 95 (56) n = 40 | 0.023* | |
LPA2 [mg/dL]^ | 22 (27) n = 37 | 14 (21) n = 37 | 0.048* | |
ApoA1 [mg/dL]° | 140 (±24) n = 40 | 141 (±24) n = 40 | 0.882 | |
ApoB [mg/dL]^ | 84 (33) n = 40 | 82 (57) n = 40 | 0.939 | |
Apo B/A1 ratio^ | 0.6 (0.2) n = 39 | 0.6 (0.3) n = 40 | 0.521 |